Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...
New options for testing and treating some of the most common sexually transmitted diseases are becoming available.
MedPage Today on MSN
FDA Approves At-Home Device for Treatment-Resistant Depression
The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker ...
The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...
The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.
News Medical on MSN
FDA-cleared ADHD device not effective in reducing symptoms
A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback